Surgical Treatment Of Tasc II A、B Femoropopliteai Arteriosclerosis (212Cases Analysis)

Purposes： To state the pathogenesis, the site, pathogenic factors, and thestaging and tapping, Pathophysiology, clinical symptoms, diagnosis,assistant examination, medical and surgical interventions of Arteriosclerosisobliterans(ASO) definitely. and to especially stress the improvement ofroutine surgical diagnosis. To compare endovascular intervention andopen surgery in TASCIIA, B femoropopliteal artery stenosis or Occlusivedisease.Methods: ASO is caused Chronic arterial occlusive by Atherosclerosis.Femoral popliteal artery is always high-occurrence part. At present, ASOpatients are800-1200million people in USA and prevalence above60ages is15.91%in China. Among them, it develops rest pain or sevre limb ischemia,amputation rate is12.2%in3months later. if Sevre limb ischemia patientswon’t be treated systematically, the amputation rate will be40%in half year,even the death rate will be20%in one year. According to2007GeneralAtlantic intervention academy renewed the consensus of surrounding diagnosisartery disease, that is TASC II PAD grading standard and pertinence treatmentguidebook. Endovascular intervention has become the commonly methods ofvascular surgery intervention intermittent claudication and sevre limbischemia. It analyses the efficacy that TASCII A, B femoropoplitealarteriosclerosis patients from2008to2012, treated by Endovascular intervention(observe group) and open surgery(control group).Then to record the apostasis of intraoperation, postoeration and follow-updatum.Results: surgical therapy needs to choose therapy according to symptomstrictly that it can reach the purpose for improving patients living standard orsurviving limbs or lives. It proves that both the medical therapy and surgicaltherapy are efficacy for ASO. Therefore, the patients who need surgicalintervention need choose homologous operation, what should assure the siteand the case. For the patients of parting TASCII A,B, who are treated bysurgical intervention through endovascular intervention and open surgery. itis separated into two groups, the observation of endovascular intervention andthe control group of route surgery. the result that both of them successful toimprove limb intermittent claudication and sevre limb ischemia symptom,which is similar with improvements of ABI. The average follow-up9.98+1.1months, the rate is69.81%. The observation group blocked16again, andcleared10by surgical intervention. Medical intervention cleared4again,amputated2, which surpassed to observation group again. And it is no differentbetween them of long-term patency rate. Some aged ASO patients have sevrecomplication who have treated by endovascular intervention, which there are11MACE,2Incision complications,1death. LOS5.51+0.36days, getting outof bed27.56+3.48hours, all of them are less than control group obviously.Conclusion: the methods of ASO treatment according to symptoms,pathology grade needs surgical intervention. Especially in TASCIIA, Bfemoropopliteal artery stenosis or chronic Occlusive disease, there were nodifference between endovascular intervention and open surgery in therapeutic effect.At the same time, endovascular intervention surpassed open surgery inthe postoperative recovery and treatment of risk.